Dr. Scott Sherr

And at the same time, like I mentioned, you're helping with the detoxification side. So you're not getting a huge amount of stress in the system, even if you're making more energy.

And at the same time, like I mentioned, you're helping with the detoxification side. So you're not getting a huge amount of stress in the system, even if you're making more energy.

And at the same time, like I mentioned, you're helping with the detoxification side. So you're not getting a huge amount of stress in the system, even if you're making more energy.

So when it comes to neurodegenerative diseases, there are a couple of studies that have been ongoing looking at methylene blue specifically for Alzheimer's. And it was a very interesting initial study that they did.

So when it comes to neurodegenerative diseases, there are a couple of studies that have been ongoing looking at methylene blue specifically for Alzheimer's. And it was a very interesting initial study that they did.

So when it comes to neurodegenerative diseases, there are a couple of studies that have been ongoing looking at methylene blue specifically for Alzheimer's. And it was a very interesting initial study that they did.

where they use very low doses methylene blue eight milligrams twice a day and this is a this is their placebo group which again is not a placebo this is very common in a lot of these studies because when you're giving somebody methylene blue you're also trying to make sure that people know that they're getting it or if they're getting it like if they're getting a high dose low dose they don't really know but the idea with methylene blue and the challenge in this case is that methylene blue makes your urine blue so what they tried to do

where they use very low doses methylene blue eight milligrams twice a day and this is a this is their placebo group which again is not a placebo this is very common in a lot of these studies because when you're giving somebody methylene blue you're also trying to make sure that people know that they're getting it or if they're getting it like if they're getting a high dose low dose they don't really know but the idea with methylene blue and the challenge in this case is that methylene blue makes your urine blue so what they tried to do

where they use very low doses methylene blue eight milligrams twice a day and this is a this is their placebo group which again is not a placebo this is very common in a lot of these studies because when you're giving somebody methylene blue you're also trying to make sure that people know that they're getting it or if they're getting it like if they're getting a high dose low dose they don't really know but the idea with methylene blue and the challenge in this case is that methylene blue makes your urine blue so what they tried to do

let's give a very low dose of methylene blue to the placebo group or the sham group and a much higher dose to the treatment group, okay? And so in the study, in this group of population, this population, methylene blue actually improved cognitive function in the placebo or sham group much more than it did in the treatment group, interestingly enough.

let's give a very low dose of methylene blue to the placebo group or the sham group and a much higher dose to the treatment group, okay? And so in the study, in this group of population, this population, methylene blue actually improved cognitive function in the placebo or sham group much more than it did in the treatment group, interestingly enough.

let's give a very low dose of methylene blue to the placebo group or the sham group and a much higher dose to the treatment group, okay? And so in the study, in this group of population, this population, methylene blue actually improved cognitive function in the placebo or sham group much more than it did in the treatment group, interestingly enough.

And so this is not actually surprising to me because what happens if you give a very large dose of methylene blue very quickly, it might be too much for the system to be able to handle. And this is very common, unfortunately, in brains that are already under significant stress.

And so this is not actually surprising to me because what happens if you give a very large dose of methylene blue very quickly, it might be too much for the system to be able to handle. And this is very common, unfortunately, in brains that are already under significant stress.

And so this is not actually surprising to me because what happens if you give a very large dose of methylene blue very quickly, it might be too much for the system to be able to handle. And this is very common, unfortunately, in brains that are already under significant stress.

So if your brain's already under significant stress because you have mild cognitive impairment, because you have Alzheimer's, as it were, then you're going to be more susceptible to the requirements for the need. You have higher requirements of things like antioxidants, for example. And if you give a very high dose of methylene blue very quickly,

So if your brain's already under significant stress because you have mild cognitive impairment, because you have Alzheimer's, as it were, then you're going to be more susceptible to the requirements for the need. You have higher requirements of things like antioxidants, for example. And if you give a very high dose of methylene blue very quickly,

So if your brain's already under significant stress because you have mild cognitive impairment, because you have Alzheimer's, as it were, then you're going to be more susceptible to the requirements for the need. You have higher requirements of things like antioxidants, for example. And if you give a very high dose of methylene blue very quickly,

you're going to induce the capacity of the brain to try to make more of that antioxidant, but you're not going to be able to do it is what it comes down to. So the key with methylene blue and neurodegenerative disorders is to really focus on low dose and titrating that dose over a period of time.

you're going to induce the capacity of the brain to try to make more of that antioxidant, but you're not going to be able to do it is what it comes down to. So the key with methylene blue and neurodegenerative disorders is to really focus on low dose and titrating that dose over a period of time.